Emma Borgeson

Dr. Emma Borgeson

University of Gothenburg, Gothenburg, Sweden
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2024 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
MSMatúš Soták
Matúš Soták
MCMadison Clark
Madison Clark
BSBianca E. Suur
Bianca E. Suur
EBEmma Borgeson
Emma Borgeson

1 July 2015 in Cell Metabolism
Verified
Journal Article
Closed access
EBEmma Borgeson
Emma Borgeson
AJAndrew M.F. Johnson
Andrew M.F. Johnson
YLYun Sok Lee
Yun Sok Lee
Andreas TillAndreas Till
Andreas Till
GSGulam Syed
Gulam Syed
CGCatherine Godson
Catherine Godson

1 April 2013 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
EBEoin Brennan
Eoin Brennan
KNKaren A. Nolan
Karen A. Nolan
EBEmma Borgeson
Emma Borgeson
OGOisín S. Gough
Oisín S. Gough
CMCaitriona M. McEvoy
Caitriona M. McEvoy
OCon behalf of the GENIE Consortium
on behalf of the GENIE Consortium
Lipoxins, which are endogenously produced lipid mediators, promote the resolution of inflammation, and may inhibit fibrosis, suggesting a possible role in modulating renal disease. Here, lipoxin A4 (LXA4) attenuated TGF-β1–induced expression of fibronectin, N-cadherin, thrombospondin, and the notch ligand jagged-1 in cultured human proximal tubular epithelial (HK-2) cells through a mechanism involving upregulation of the microRNA let-7c. Conversely, TGF-β1 suppressed expression of let-7c. In cells pretreated with LXA4, upregulation of let-7c persisted despite subsequent stimulation with TGF-β1. In the unilateral ureteral obstruction model of renal fibrosis, let-7c upregulation was induced by administering an LXA4 analog. Bioinformatic analysis suggested that targets of let-7c include several members of the TGF-β1 signaling pathway, including the TGF-β receptor type 1. Consistent with this, LXA4-induced upregulation of let-7c inhibited both the expression of TGF-β receptor type 1 and the response to TGF-β1. Overexpression of let-7c mimicked the antifibrotic effects of LXA4 in renal epithelia; conversely, anti-miR directed against let-7c attenuated the effects of LXA4. Finally, we observed that several let-7c target genes were upregulated in fibrotic human renal biopsies compared with controls. In conclusion, these results suggest that LXA4-mediated upregulation of let-7c suppresses TGF-β1–induced fibrosis and that expression of let-7c targets is dysregulated in human renal fibrosis.

31 May 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
EBEmma Borgeson
Emma Borgeson
Neil G. DochertyNeil G. Docherty
Neil G. Docherty
MMMadeline Murphy
Madeline Murphy
KRKaren Rodgers
Karen Rodgers
ARAidan Ryan
Aidan Ryan
CGCatherine Godson
Catherine Godson
Unresolved inflammation underlies the development of fibrosis and organ failure. Here, we investigate the potential of the proresolving eicosanoid lipoxinA 4 (LXA 4 ) and its synthetic analog benzo‐LXA 4 to prophylactically modulate fibrotic and inflammatory responses in a model of early renal fibrosis, unilateral ureteric obstruction (UUO). Male Wistar rats ( Animalia, Chordata, Rattus norvegicus ) were injected intravenously with vehicle (0.1% ethanol), LXA 4 (45 μg/250‐g rat), or benzo‐LXA 4 (15 μg/250‐g rat) 15 min prior to surgery and sacrificed 3 d postligation. Renal gene and protein expression, collagen deposition, macrophage infiltration, and apoptosis were analyzed using manipulated kidneys from sham operations as control. Lipoxins (LXs) attenuated collagen deposition and renal apoptosis ( P <0.05) and shifted the inflammatory milieu toward resolution, inhibiting TNF‐α and IFN‐γ expression, while stimulating proresolving IL‐10. LXs attenuated UUO‐induced activation of MAP kinases, Akt, and Smads ( P <0.05) in injured kidneys. We explored whether the underlying mechanism reflected LX‐induced modulation of fibroblast activation. Using cultured rat renal NRK‐49F fibroblasts, we report that LXA 4 (1 nM) inhibits TGF‐β1 (10 ng/ml)‐induced activation of Smad2 and MAP‐kinases ( P <0.05), and furthermore, LXA 4 reduced TGF‐β1‐stimulated PAI‐1 luciferase activation ( P <0.05) relative to vehicle‐stimulated cells. We propose that LXs may represent a potentially useful and novel therapeutic strategy for consideration in the context of renal fibrosis.—Börgeson, E., Docherty, N. G., Murphy, M., Rodgers, K., Ryan, A., O'Sullivan, T. P., Guiry, P. J., Goldschmeding, R., Higgins, D. F., Godson, C. Lipoxin A4 and benzo‐lipoxin A4 attenuate experimental renal fibrosis. FASEB J. 25, 2967–2979 (2011). www.fasebj.org

14 June 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
EBEmma Borgeson
Emma Borgeson
FMFiona McGillicuddy McGillicuddy
Fiona McGillicuddy McGillicuddy
KHKaren A. Harford
Karen A. Harford
NCNiamh Corrigan
Niamh Corrigan
DHDebra F. Higgins
Debra F. Higgins
CGCatherine Godson
Catherine Godson
Aging and adiposity are associated with chronic low‐grade inflammation, which underlies the development of obesity‐associated complications, including type 2 diabetes mellitus (T2DM). The mechanisms underlying adipose inflammation may include macrophage infiltration and activation, which, in turn, affect insulin sensitivity of adipocytes. There is a growing appreciation that specific lipid mediators (including lipoxins, resolvins, and protectins) can promote the resolution of inflammation. Here, we investigated the effect of lipoxin A 4 (LXA 4 ), the predominant endogenously generated lipoxin, on adipose tissue inflammation. Using adipose tissue explants from perigonadal depots of aging female C57BL/6J mice (Animalia, Chordata, Mus musculus) as a model of age‐associated adipose inflammation, we report that LXA 4 (1 nM) attenuates adipose inflammation, decreasing IL‐6 and increasing IL‐10 expression ( P <0.05). The altered cytokine milieu correlated with increased GLUT‐4 and IRS‐1 expression, suggesting improved insulin sensitivity. Further investigations revealed the ability of LXA 4 to rescue macrophage‐induced desensitization to insulin‐stimulated signaling and glucose uptake in cultured adipocytes, using vehicle‐stimulated cells as controls. This was associated with preservation of Akt activation and reduced secretion of proinflammatory cytokines, including TNF‐ α. We therefore propose that LXA 4 may represent a potentially useful and novel therapeutic strategy to subvert adipose inflammation and insulin resistance, key components of T2DM.—Börgeson, E., McGillicuddy, F. C., Harford, K. A., Corrigan, N., Higgins, D. F., Maderna, P., Roche, H. M., Godson C. Lipoxin A 4 attenuates adipose inflammation. FASEB J. 26, 4287–4294 (2012). www.fasebj.org

1 April 2011 in Infection and Immunity
Verified
Journal Article
Closed access
EBEmma Borgeson
Emma Borgeson
JLJohanna Lönn
Johanna Lönn
IBIda Bergström
Ida Bergström
VBVeronika Patcha Brodin
Veronika Patcha Brodin
SRSofia Ramström
Sofia Ramström
TBTorbjörn Bengtsson
Torbjörn Bengtsson
Porphyromonas gingivalis is an etiological agent that is strongly associated with periodontal disease, and it correlates with numerous inflammatory disorders, such as cardiovascular disease. Circulating bacteria may contribute to atherogenesis by promoting CD11b/CD18-mediated interactions between neutrophils and platelets, causing reactive oxygen species (ROS) production and aggregation. Lipoxin A 4 (LXA 4 ) is an endogenous anti-inflammatory and proresolving mediator that is protective of inflammatory disorders. The aim of this study was to investigate the effect of LXA 4 on the P. gingivalis -induced activation of neutrophils and platelets and the possible involvement of Rho GTPases and CD11b/CD18 integrins. Platelet/leukocyte aggregation and ROS production was examined by lumiaggregometry and fluorescence microscopy. Integrin activity was studied by flow cytometry, detecting the surface expression of CD11b/CD18 as well as the exposure of the high-affinity integrin epitope, whereas the activation of Rac2/Cdc42 was examined using a glutathione S -transferase pulldown assay. The study shows that P. gingivalis activates Rac2 and Cdc42 and upregulates CD11b/CD18 and its high-affinity epitope on neutrophils, and that these effects are diminished by LXA 4 . Furthermore, we found that LXA 4 significantly inhibits P. gingivalis -induced aggregation and ROS generation in whole blood. However, in platelet-depleted blood and in isolated neutrophils and platelets, LXA 4 was unable to inhibit either aggregation or ROS production, respectively. In conclusion, this study suggests that LXA 4 antagonizes P. gingivalis -induced cell activation in a manner that is dependent on leukocyte-platelet interaction, likely via the inhibition of Rho GTPase signaling and the downregulation of CD11b/CD18. These findings may contribute to new strategies in the prevention and treatment of periodontitis-induced inflammatory disorders, such as atherosclerosis.